3 results
Approved WMOCompleted
The primary objective is to assess the clinical efficacy of siltuximab (a chimeric (murine-human) IgG1* mAb that specifically binds human IL-6 with high affinity and prevents its interaction with the IL-6 receptor, glycoprotein (GP) 80),…
Approved WMOCompleted
To compare the cost-effectiveness and effectiveness of MRA therapy versus CPAP therapy in patients with moderate OSAS.
Approved WMORecruiting
To determine if EBUS / EUS-B guided nodal/lung tumor sampling with 22 Gauge (G) TBNB (Acquire**) needles results in improved tissue core sample acquisition in comparison to standard 22 G TBNA needles for the diagnosis and staging of lung cancer.